Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Viking Thera (VKTX)

Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,815,534
  • Shares Outstanding, K 110,268
  • Annual Sales, $ 0 K
  • Annual Income, $ -85,900 K
  • 60-Month Beta 1.04
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.95
Trade VKTX with:

Options Overview Details

View History
  • Implied Volatility 104.92% ( +7.14%)
  • Historical Volatility 67.69%
  • IV Percentile 58%
  • IV Rank 44.66%
  • IV High 234.70% on 02/16/24
  • IV Low 0.20% on 02/27/24
  • Put/Call Vol Ratio 0.17
  • Today's Volume 20,876
  • Volume Avg (30-Day) 15,273
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 204,157
  • Open Int (30-Day) 185,487

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.25
  • Number of Estimates 8
  • High Estimate -0.17
  • Low Estimate -0.31
  • Prior Year -0.19
  • Growth Rate Est. (year over year) -31.58%

Price Performance

See More
Period Period Low Period High Performance
1-Month
48.20 +9.42%
on 06/14/24
65.90 -19.97%
on 05/28/24
-11.49 (-17.89%)
since 05/21/24
3-Month
48.20 +9.42%
on 06/14/24
89.10 -40.81%
on 03/26/24
-17.85 (-25.29%)
since 03/21/24
52-Week
8.28 +536.96%
on 10/26/23
99.41 -46.95%
on 02/28/24
+31.28 (+145.76%)
since 06/21/23

Most Recent Stories

More News
The Best Biotech Stock to Invest $1,000 in Right Now

This stock may not be a slam dunk, but it's looking very promising.

MDGL : 278.42 (+3.97%)
LLY : 883.88 (-0.24%)
NVO : 141.96 (+0.69%)
VKTX : 52.74 (+4.58%)
3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street

These high-flying stocks could have more room to run if analysts are right.

MRK : 130.72 (+0.81%)
SMMT : 7.93 (+1.67%)
SMCI : 905.26 (-1.35%)
VKTX : 52.74 (+4.58%)
2 Growth Stocks Wall Street Analysts Think Can Soar by at Least 80%

There's a lot of hope for these stocks, but there's also a fair amount of risk.

VKTX : 52.74 (+4.58%)
RIOT : 9.55 (-8.35%)
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It

Just because a stock has amazing growth prospects doesn't mean you should ignore its valuation.

LLY : 883.88 (-0.24%)
VKTX : 52.74 (+4.58%)
Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity Drug

Novo Nordisk's competition in the obesity drug market is heating up.

NVO : 141.96 (+0.69%)
LLY : 883.88 (-0.24%)
VKTX : 52.74 (+4.58%)
Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals

Success isn't guaranteed, but both companies could become big winners.

VKTX : 52.74 (+4.58%)
MDGL : 278.42 (+3.97%)
This High-Flying Stock Just Announced More Good News: Time to Buy?

The biotech's prospects keep getting brighter.

VKTX : 52.74 (+4.58%)
Structure Therapeutics vs. Viking Therapeutics: Which Weight-Loss Drug Stock Wins?

With weight-loss drugs gaining traction, which biopharma stock wins?

NVO : 141.96 (+0.69%)
LLY : 883.88 (-0.24%)
GPCR : 45.57 (-2.52%)
VKTX : 52.74 (+4.58%)
$SPX : 5,464.62 (-0.16%)
$IUXX : 19,700.43 (-0.26%)
JPM : 196.30 (-1.19%)
Is Viking Therapeutics Stock a Buy on the Dip?

Short-term thinking is creating an intriguing opportunity for investors.

VKTX : 52.74 (+4.58%)
NVO : 141.96 (+0.69%)
LLY : 883.88 (-0.24%)
1 Disruptive Biotech Stock to Buy Now, and 1 to Consider

Both of these companies could soon set the standard in their fields.

LLY : 883.88 (-0.24%)
VKTX : 52.74 (+4.58%)
RXRX : 8.85 (-3.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA...

See More

Key Turning Points

3rd Resistance Point 58.32
2nd Resistance Point 56.14
1st Resistance Point 54.44
Last Price 52.74
1st Support Level 50.56
2nd Support Level 48.38
3rd Support Level 46.68

See More

52-Week High 99.41
Fibonacci 61.8% 64.60
Fibonacci 50% 53.85
Last Price 52.74
Fibonacci 38.2% 43.09
52-Week Low 8.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar